Ontology highlight
ABSTRACT:
SUBMITTER: Stemmer SM
PROVIDER: S-EPMC5591314 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Stemmer Salomon M SM Steiner Mariana M Rizel Shulamith S Geffen David B DB Nisenbaum Bella B Peretz Tamar T Soussan-Gutman Lior L Bareket-Samish Avital A Isaacs Kevin K Rosengarten Ora O Fried Georgeta G McCullough Debbie D Svedman Christer C Shak Steven S Liebermann Nicky N Ben-Baruch Noa N
NPJ breast cancer 20170908
The Recurrence Score® is increasingly used in node-positive ER+ HER2-negative breast cancer. This retrospective analysis of a prospectively designed registry evaluated treatments/outcomes in node-positive breast cancer patients who were Recurrence Score-tested through Clalit Health Services from 1/2006 through 12/2011 (<i>N</i> = 709). Medical records were reviewed to verify treatments/recurrences/survival. Median follow-up, 5.9 years; median age, 62 years; 53.9% grade 2; 69.8% tumors ≤ 2 cm; 84 ...[more]